Free Trial

Sequoia Financial Advisors LLC Grows Stock Position in HealthEquity, Inc. $HQY

HealthEquity logo with Medical background

Key Points

  • Sequoia Financial Advisors LLC significantly increased its stake in HealthEquity, Inc. by 78.6% during Q2, bringing its total to 29,731 shares valued at approximately $3.12 million.
  • Multiple institutional investors also expanded their positions, with Farther Finance Advisors LLC raising its stake by 232.4% and other firms like Larson Financial Group LLC increasing their holdings by as much as 1,366.0%.
  • HealthEquity's stock experienced recent insider selling, with executives Michael Henry Fiore and Delano Ladd offloading shares, contributing to a decrease in their respective holdings by 3.45% and 7.02%.
  • MarketBeat previews top five stocks to own in November.

Sequoia Financial Advisors LLC increased its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 78.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,731 shares of the company's stock after buying an additional 13,086 shares during the period. Sequoia Financial Advisors LLC's holdings in HealthEquity were worth $3,115,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its stake in HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock valued at $26,000 after purchasing an additional 172 shares during the last quarter. WPG Advisers LLC acquired a new stake in HealthEquity during the 1st quarter worth approximately $28,000. Sellwood Investment Partners LLC acquired a new stake in HealthEquity during the 2nd quarter worth approximately $58,000. Northwestern Mutual Wealth Management Co. increased its position in HealthEquity by 176.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after purchasing an additional 418 shares in the last quarter. Finally, Larson Financial Group LLC increased its position in HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the firm's stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Delano Ladd sold 6,000 shares of the firm's stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the sale, the executive vice president owned 79,456 shares of the company's stock, valued at $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

HealthEquity Trading Down 1.6%

Shares of HQY stock opened at $92.55 on Thursday. The stock has a 50-day simple moving average of $91.75 and a 200 day simple moving average of $93.94. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The stock has a market capitalization of $7.97 billion, a P/E ratio of 56.09, a P/E/G ratio of 1.35 and a beta of 0.47. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The business had revenue of $325.80 million during the quarter, compared to analysts' expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. JPMorgan Chase & Co. increased their target price on HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Jefferies Financial Group upped their price target on HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada upped their price target on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research report on Wednesday, September 3rd. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of HealthEquity in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $121.31.

Get Our Latest Analysis on HealthEquity

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.